Methoxetamine: Difference between revisions
>Unity Changed intro sentence to conform to new standard where we list the substitutive chemical name first. Please follow this standard for all new substance articles as well as for editing old ones. |
>Unity Reduced wordiness |
||
Line 5: | Line 5: | ||
| ''[[Methoxetamine/Summary|Summary sheet: Methoxetamine]]'' | | ''[[Methoxetamine/Summary|Summary sheet: Methoxetamine]]'' | ||
|} | |} | ||
'''3'-MeO-2-Oxo-PCE''' (commonly known | '''3'-MeO-2-Oxo-PCE''' (commonly known as'''Methoxetamine''', '''MXE''', and also as '''Mexxy''') is a synthetic [[psychoactive class::dissociative]] of the [[Chemical class::arylcyclohexylamine]] class. | ||
This substance was originally developed as a [[research chemical]] through the use of intelligent drug design, as a potential treatment for [https://en.wikipedia.org/wiki/Phantom_pain Phantom Limb Syndrome] among other ailments.<ref>Interview with a ketamine chemist | http://www.viceland.com/int/v18n2/htdocs/interview-with-ketamine-chemist-704.php</ref> It is a chemical derivative of [[ketamine]] that also contains structural features of [[phencyclidine]] (PCP) and [[3-MeO-PCP]]. | This substance was originally developed as a [[research chemical]] through the use of intelligent drug design, as a potential treatment for [https://en.wikipedia.org/wiki/Phantom_pain Phantom Limb Syndrome] among other ailments.<ref>Interview with a ketamine chemist | http://www.viceland.com/int/v18n2/htdocs/interview-with-ketamine-chemist-704.php</ref> It is a chemical derivative of [[ketamine]] that also contains structural features of [[phencyclidine]] (PCP) and [[3-MeO-PCP]]. |